DNA stock results show that Ginkgo Bioworks Holdings missed analyst estimates for earnings per share but beat on revenue for the second quarter of DNA. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets. The share price of Ginkgo Bioworks Holdings, Inc. as of September 3, is $ / share. This is a decrease of % from the prior week. The Factor. The current price of DNA is USD — it has decreased by −% in the past 24 hours. Watch Ginkgo Bioworks Holdings, Inc. stock price performance more. Based on 4 Wall Street analysts offering 12 month price targets for Ginkgo Bioworks Holdings in the last 3 months. The average price target is $ with a.
Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. DNA will report earnings. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations. Ginkgo Bioworks DNA:NYSE · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/06/23 · 52 Week Low · 52 Week. Stock Price Forecast. The 5 analysts with month price forecasts for DNA stock have an average target of , with a low estimate of and a high estimate. r/ginkgobioworks - Ginkgo Bioworks Forms Partnership With Vitales to Develop Sustainable Biocontrols for Brazilian stock just received a very large contract. DNA - Ginkgo Bioworks Holdings, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE). Stock Info · SEC Filings · Quarterly Reports · Annual Reports · Sustainability · Governance · Executive Management · Board of Directors · Committee Composition. Ginkgo Bioworks Holdings (NYSE:DNA) Stock, Analyst Ratings, Price Targets, Forecasts Ginkgo Bioworks Holdings Inc has a consensus price target of $ based. Other Biotechnology & Medical Research ; GINKGO BIOWORKS HOLDINGS, INC. Stock Ginkgo Bioworks Holdings, Inc. %, % ; LONZA GROUP AG · Stock Lonza Group. Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Our cell programming platform. View Ginkgo Bioworks Holdings, Inc DNA investment & stock information. Get the latest Ginkgo Bioworks Holdings, Inc DNA detailed stock quotes, stock data.
Ginkgo Bioworks (DNA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong. DNA | Complete Ginkgo Bioworks Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get the latest updates on Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) pre market trades, share volumes, and more. What is Ginkgo Bioworks's stock symbol? The ticker symbol for Ginkgo Bioworks is DNA. What is the current stock price of Ginkgo Bioworks? As of DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A. 13, $ $ (%). Today. Watchers, 13, Wk Low, $ Wk High, $ The real value of Ginkgo Stock, also known as its intrinsic value, is the underlying worth of Ginkgo Bioworks Holdings Company, which is reflected in its stock. Real time Ginkgo Bioworks (DNA) stock price quote, stock graph, news & analysis. Ginkgo Bioworks Holdings (NYSE:DNA) is a biotechnology company that offers a platform for cell programming that enables the biological production of various. Ginkgo Bioworks Holdings Inc (DNA) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus.
Earnings Growth. Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($) to ($) per share. Price to Earnings Ratio vs. the. Discover real-time Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) stock prices, quotes, historical data, news, and Insights for informed trading. Volume, M. Market Value, $M. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. Ginkgo Bioworks Holdings market cap as of August 30, is $B. Compare DNA With Other Stocks. According to Ginkgo Bioworks 's latest financial reports and stock price the company's current number of shares outstanding is 2,,, At the end of
Omnichannel Pharma Marketing | Start Trading